The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a decade, its potential therapeutic benefit in the treatment of breast cancer has also been studied.

The study supports the therapeutic benefit of this drug in postmenopausal patients with hormone-receptor negative breast tumours and RANK protein expression. "These results revive the option of ...

Trophoblast cell-surface antigen 2 is a biomarker and potential therapeutic target in human colon cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...

With the aim of selecting patients who could benefit from denosumab therapy, scientists from the Spanish National Cancer Research Centre (CNIO) and the Bellvitge Biomedical Research Institute (IDIBELL ...